Format
Sort by

Send to

Choose Destination

Search results

Items: 8

1.

State of affairs in use of steroids in diffuse intrinsic pontine glioma: an international survey and a review of the literature.

Veldhuijzen van Zanten SE, Cruz O, Kaspers GJ, Hargrave DR, van Vuurden DG; SIOPE DIPG Network.

J Neurooncol. 2016 Jul;128(3):387-94. doi: 10.1007/s11060-016-2141-x. Epub 2016 May 13. Review.

2.

Commentary on "Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes".

Jansen MH, Veldhuijzen van Zanten SE, Heymans MW, Hargrave D, Kramm CM, Van Vuurden DG.

Acta Neuropathol. 2016 May;131(5):793-4. doi: 10.1007/s00401-016-1567-8. Epub 2016 Mar 30. No abstract available.

PMID:
27026412
3.

Palliative and end-of-life care for children with diffuse intrinsic pontine glioma: results from a London cohort study and international survey.

Veldhuijzen van Zanten SE, van Meerwijk CL, Jansen MH, Twisk JW, Anderson AK, Coombes L, Breen M, Hargrave OJ, Hemsley J, Craig F, Cruz O, Kaspers GJ, van Vuurden DG, Hargrave DR; SIOPE DIPG Network.

Neuro Oncol. 2016 Apr;18(4):582-8. doi: 10.1093/neuonc/nov250. Epub 2015 Oct 11.

PMID:
26459800
4.

A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands.

Veldhuijzen van Zanten SE, Jansen MH, Sanchez Aliaga E, van Vuurden DG, Vandertop WP, Kaspers GJ.

Expert Rev Anticancer Ther. 2015 Feb;15(2):157-64. doi: 10.1586/14737140.2015.974563. Epub 2014 Nov 29.

PMID:
25435089
5.

Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria.

Jansen MH, Veldhuijzen van Zanten SE, Sanchez Aliaga E, Heymans MW, Warmuth-Metz M, Hargrave D, van der Hoeven EJ, Gidding CE, de Bont ES, Eshghi OS, Reddingius R, Peeters CM, Schouten-van Meeteren AY, Gooskens RH, Granzen B, Paardekooper GM, Janssens GO, Noske DP, Barkhof F, Kramm CM, Vandertop WP, Kaspers GJ, van Vuurden DG.

Neuro Oncol. 2015 Jan;17(1):160-6. doi: 10.1093/neuonc/nou104. Epub 2014 Jun 5.

6.

18 F-FDG PET standard uptake values of the normal pons in children: establishing a reference value for diffuse intrinsic pontine glioma.

Jansen MH, Kloet RW, van Vuurden DG, Veldhuijzen van Zanten SE, Witte BI, Goldman S, Vandertop WP, Comans EF, Hoekstra OS, Boellaard R, Kaspers GJ.

EJNMMI Res. 2014 Jan 28;4(1):8. doi: 10.1186/2191-219X-4-8.

7.

Newborn literacy program effective in increasing maternal engagement in literacy activities: an observational cohort study.

Veldhuijzen van Zanten S, Coates C, Hervas-Malo M, McGrath PJ.

BMC Pediatr. 2012 Jul 16;12:100. doi: 10.1186/1471-2431-12-100.

8.

A small-molecule IAP inhibitor overcomes resistance to cytotoxic therapies in malignant gliomas in vitro and in vivo.

Ziegler DS, Keating J, Kesari S, Fast EM, Zawel L, Ramakrishna N, Barnes J, Kieran MW, Veldhuijzen van Zanten SE, Kung AL.

Neuro Oncol. 2011 Aug;13(8):820-9. doi: 10.1093/neuonc/nor066. Epub 2011 Jul 1.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk